Literature DB >> 15369655

Impact of the Salmonella status of market-age pigs and the pre-slaughter process on Salmonella caecal contamination at slaughter.

Pierre-Alexandre Beloeil1, Claire Chauvin, Karine Proux, François Madec, Philippe Fravalo, Ahmadou Alioum.   

Abstract

The aim of this study was to evaluate the impact of the pre-slaughter process on Salmonella caecal contamination of pigs at slaughter. An observational study was carried out in 2001 on 101 conventional farrow-to-finish pig farms. On each farm, one batch of contemporary pigs was followed from the end of the fattening period until slaughter. The Salmonella bacteriological status of the batches was assessed by environmental samples of faecal material. The serological Salmonella status was obtained on 30 individually identified market-age pigs using an indirect ELISA test. At the slaughterhouse, 25 g of caecal contents were taken from 10 of the identified pigs. Faecal and caecal material were analysed according to a classical bacteriological method. A questionnaire was designed to obtain information about the type of feeding during the fattening period (dry versus wet), the duration of fasting on the farm before leaving for the slaughterhouse, the duration of transport between the farm and the slaughterhouse, the holding time in lairage at the slaughterhouse and loading and unloading conditions on the farm and at the slaughterhouse. To assess the relationships between these factors and the Salmonella caecal status of the pigs and the batches, two logistic models were fitted at the individual and at the batch level, respectively. The first analysis was performed using a random effects logistic regression model. The second analysis was based on a cumulative logit model with a positive caecal rate classified into three classes as the outcome variable. The results showed that the Salmonella status of market-age pigs assessed on the farm either by serological or bacteriological examinations and the time spent in lairage before slaughtering played a crucial role on caecal contamination. In the light of these results, actions should be considered both on the farm and at the slaughterhouse to decrease the risk of Salmonella contamination of the caecal contents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15369655     DOI: 10.1051/vetres:2004028

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  6 in total

1.  Evaluation of enzyme-linked immunosorbent assay (ELISA) tests and culture for determining Salmonella status of a pig herd.

Authors:  A Farzan; R M Friendship; C E Dewey
Journal:  Epidemiol Infect       Date:  2006-07-07       Impact factor: 2.451

2.  Evolution of ß-lactams, fluroquinolones and colistin resistance and genetic profiles in Salmonella isolates from pork in northern Italy.

Authors:  Ilaria Carmosino; Silvia Bonardi; Martina Rega; Andrea Luppi; Luca Lamperti; Maria Cristina Ossiprandi; Cristina Bacci
Journal:  Ital J Food Saf       Date:  2022-06-21

3.  Salmonella Shedding in Slaughter Pigs and the Use of Esterified Formic Acid in the Drinking Water as a Potential Abattoir-Based Mitigation Measure.

Authors:  María Bernad-Roche; Alejandro Casanova-Higes; Clara María Marín-Alcalá; Raúl Carlos Mainar-Jaime
Journal:  Animals (Basel)       Date:  2022-06-23       Impact factor: 3.231

4.  Phage therapy to reduce preprocessing Salmonella infections in market-weight swine.

Authors:  Samantha K Wall; Jiayi Zhang; Marcos H Rostagno; Paul D Ebner
Journal:  Appl Environ Microbiol       Date:  2009-10-23       Impact factor: 4.792

Review 5.  The commercial impact of pig Salmonella spp. infections in border-free markets during an economic recession.

Authors:  G Evangelopoulou; S Kritas; G Christodoulopoulos; A R Burriel
Journal:  Vet World       Date:  2015-03-05

Review 6.  Prevalence and risk factors for bacterial food-borne zoonotic hazards in slaughter pigs: a review.

Authors:  J Fosse; H Seegers; C Magras
Journal:  Zoonoses Public Health       Date:  2009-01-17       Impact factor: 2.702

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.